Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × Pemetrexed × Clear all

NCT00035035 2006-07-19

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Phase 3 Completed

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms